EPSILON HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.024 AUD | -.--% |
|
-.--% | -.--% |
| 2023 | Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting | CI |
| 2023 | Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting | CI |
| Sales 2021 | 5.5M 3.59M 288M | Sales 2022 | 7.11M 4.65M 372M | Capitalization | 7.51M 4.9M 393M |
|---|---|---|---|---|---|
| Net income 2021 | -9M -5.88M -471M | Net income 2022 | -13M -8.49M -680M | EV / Sales 2021 | 3.26 x |
| Net Debt 2021 | 2.1M 1.37M 110M | Net Debt 2022 | 2.34M 1.53M 122M | EV / Sales 2022 | 1.38 x |
| P/E ratio 2021 |
-1.48
x | P/E ratio 2022 |
-0.38
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.39% |
More Fundamentals
* Assessed data
More news
More press releases
| 6 months | -17.24% |
1 year
0.02
0.03
3 years
0.020.21
5 years
0.020.60
10 years
0.021.15
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 11-20 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 22/12/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alan Beasley
CHM | Chairman | - | 28/08/16 |
Stuart Cameron
BRD | Director/Board Member | - | 26/10/22 |
Xiao Cui
CHM | Chairman | - | 27/10/22 |
Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
Sector
Pharmaceuticals
Calendar
28/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4.7M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- EPN Stock
